Synergy Pharma (SGYP) Adds to Gains as Analyst Stokes Speculation Fire
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Synergy Pharma (NASDAQ: SGYP) is adding to recent gains after Citi highlighted the company as a biotech takeover target for Takeda yesterday. Share are up 8.5% after jumping 8.8% yesterday. Volume is running 4x normal.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Acacia Communications (ACIA) Mentioned as Short in Lakewood Capital's Q3 Letter - Bloomberg
- Birks Group, Inc. (BGI) Climbs to Session High, Up 40%
- Kellogg (K) on Watch Amid Unconfirmed Takeover Chatter
Create E-mail Alert Related CategoriesMomentum Movers, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!